Medtronic annual capital expenditures (capex)
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Medtronic Capital Expenditures (CapEx) Growth & History (MDT)
Medtronic's capital expenditures (capex) was $1.90B for fiscal 2026.
View full Medtronic company overviewMedtronic annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $1.90B | $45.0M | +2.42% |
| 2025 | 2025-04-25 | $1.86B | $272.0M | +17.14% |
| 2024 | 2024-04-26 | $1.59B | $128.0M | +8.77% |
| 2023 | 2023-04-28 | $1.46B | $91.0M | +6.65% |
| 2022 | 2022-04-29 | $1.37B | $13.0M | +0.96% |
| 2021 | 2021-04-30 | $1.35B | $142.0M | +11.71% |
| 2020 | 2020-04-24 | $1.21B | $79.0M | +6.97% |
| 2019 | 2019-04-26 | $1.13B | $66.0M | +6.18% |
| 2018 | 2018-04-27 | $1.07B | −$186.0M | −14.83% |
| 2017 | 2017-04-28 | $1.25B | $208.0M | +19.89% |
| 2016 | 2016-04-29 | $1.05B | $475.0M | +83.19% |
| 2015 | 2015-04-24 | $571.0M | $175.0M | +44.19% |
| 2014 | 2014-04-25 | $396.0M | −$61.0M | −13.35% |
| 2013 | 2013-04-26 | $457.0M | — | — |
Medtronic quarterly capital expenditures (capex)
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $503.0M | −$1.0M | −0.20% |
| Q4 2026 | 2026-04-24 | $488.0M | $29.0M | +6.32% |
| Q3 2026 | 2026-01-31 | $444.0M | −$32.0M | −6.72% |
| Q3 2026 | 2026-01-23 | $444.0M | −$32.0M | −6.72% |
| Q2 2026 | 2025-10-24 | $468.0M | $64.0M | +15.84% |
| Q1 2026 | 2025-07-25 | $504.0M | −$16.0M | −3.08% |
| Q4 2025 | 2025-04-25 | $459.0M | $33.0M | +7.75% |
| Q3 2025 | 2025-01-24 | $476.0M | $130.0M | +37.57% |
| Q2 2025 | 2024-10-25 | $404.0M | −$57.0M | −12.36% |
| Q1 2025 | 2024-07-26 | $520.0M | $166.0M | +46.89% |
| Q4 2024 | 2024-04-26 | $426.0M | $48.0M | +12.70% |
| Q3 2024 | 2024-01-26 | $346.0M | $14.0M | +4.22% |
| Q2 2024 | 2023-10-27 | $461.0M | $138.0M | +42.72% |
| Q1 2024 | 2023-07-28 | $354.0M | −$72.0M | −16.90% |
| Q4 2023 | 2023-04-28 | $378.0M | −$11.0M | −2.83% |
| Q3 2023 | 2023-01-27 | $332.0M | $2.0M | +0.61% |
| Q2 2023 | 2022-10-28 | $323.0M | $52.0M | +19.19% |
| Q1 2023 | 2022-07-29 | $426.0M | $48.0M | +12.70% |
| Q4 2022 | 2022-04-29 | $389.0M | $12.0M | +3.18% |
| Q3 2022 | 2022-01-28 | $330.0M | −$33.0M | −9.09% |
| Q2 2022 | 2021-10-29 | $271.0M | −$10.0M | −3.56% |
| Q1 2022 | 2021-07-30 | $378.0M | $44.0M | +13.17% |
| Q4 2021 | 2021-04-30 | $377.0M | $41.0M | +12.20% |
| Q3 2021 | 2021-01-29 | $363.0M | $70.0M | +23.89% |
| Q2 2021 | 2020-10-30 | $281.0M | −$2.0M | −0.71% |
| Q1 2021 | 2020-07-31 | $334.0M | $33.0M | +10.96% |
| Q4 2020 | 2020-04-24 | $336.0M | $1.0M | +0.30% |
| Q3 2020 | 2020-01-24 | $293.0M | −$9.0M | −2.98% |
| Q2 2020 | 2019-10-25 | $283.0M | $77.0M | +37.38% |
| Q1 2020 | 2019-07-26 | $301.0M | $10.0M | +3.44% |
| Q4 2019 | 2019-04-26 | $335.0M | $43.0M | +14.73% |
| Q3 2019 | 2019-01-25 | $302.0M | $50.0M | +19.84% |
| Q2 2019 | 2018-10-26 | $206.0M | −$40.0M | −16.26% |
| Q1 2019 | 2018-07-27 | $291.0M | $13.0M | +4.68% |
| Q4 2018 | 2018-04-27 | $292.0M | −$38.0M | −11.52% |
| Q3 2018 | 2018-01-26 | $252.0M | −$74.0M | −22.70% |
| Q2 2018 | 2017-10-27 | $246.0M | −$22.0M | −8.21% |
| Q1 2018 | 2017-07-28 | $278.0M | −$52.0M | −15.76% |
| Q4 2017 | 2017-04-28 | $330.0M | −$23.0M | −6.52% |
| Q3 2017 | 2017-01-27 | $326.0M | $79.0M | +31.98% |
| Q2 2017 | 2016-10-28 | $268.0M | $46.0M | +20.72% |
| Q1 2017 | 2016-07-29 | $330.0M | $106.0M | +47.32% |
| Q4 2016 | 2016-04-29 | $353.0M | $98.0M | +38.43% |
| Q3 2016 | 2016-01-29 | $247.0M | $141.0M | +133.02% |
| Q2 2016 | 2015-10-30 | $222.0M | $121.0M | +119.80% |
| Q1 2016 | 2015-07-31 | $224.0M | $115.0M | +105.50% |
| Q4 2015 | 2015-04-24 | $255.0M | — | — |
| Q3 2015 | 2015-01-23 | $106.0M | — | — |
| Q2 2015 | 2014-10-24 | $101.0M | — | — |
| Q1 2015 | 2014-07-25 | $109.0M | — | — |
Medtronic capital expenditures (capex) trends
Over the last five fiscal years, Medtronic's capital expenditures (capex) increased from $1.35B to $1.90B, a change of $549.0M. The latest reported quarter, Q1 2027, shows $503.0M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...